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Introduction 
Capillary  electrophoresis  (CE)  is  an  instrumental 
evolution  of  traditional  electrophoretic  techniques, 
where separation occurs in fused-silica capillaries and 
involves  application  of  high  voltages  across  buffer 
filled capillaries in order to achieve separation. Due to 
its  speed  of  analysis,  high  efficiency,  automated 
analytical  equipment,  low  reagents  and  sample 
consumption  and  rapid  method  development,  CE  has 
gained  momentum  in  pharmaceutical  analysis,  being 
regarded  today  as  an  alternative  and  also  a 
complementary technique to the more frequently used 
high performance liquid chromatography (HPLC). 
CE is actually a range of separation techniques based 
on  different  separation  principles:  capillary  zone 
electrophoresis–CZE (based on the differences between 
the electrohoretic mobilities of the analytes), micellar 
electrokinetic  capillary  chromatography–MEKC 
(separation  of  neutral  compounds  using  surfactant 
micelles), capillary gel electrophoresis–CGE (filtration 
of analytes through a gel network), capillary isoelectric 
focusing–CIEF  (separation  of  zwitterionic  analytes 
within  a  pH  gradient),  capillary 
electrochromatography–CEC (separation of analytes in 
a  capillary  filled  with  a  chromatographic  stationary 
phase).
1-4 
Various  CE  techniques  offer  various  possibilities  for 
pharmaceutical analysis. Depending on the complexity 
of  the  sample,  the  nature  of  its  components,  on  the 
intended  application  and  the  nature  of  the  analytes, 
each  of  these  techniques  will  provide  various 
advantages for the separation and detection of different 
pharmaceutical substances. 
Substances  of  pharmaceutical  interest  are  usually 
neutral  from  electrophoretic  point  of  view  and  also 
frequently  the  separation  of  substances  with  very 
similar  structural  and  physico-chemical  properties  is 
required.  Being  based  on  differences  between  the 
electrophoretic  mobilities  of  the  analytes,  the  classic 
CZE method is not suited for the separation of neutral 
substances, which migrate towards the detector with the 
same  velocity  as  the  electro-osmotic  flow  (EOF). 
MEKC is an electrophoretic technique developed in the 
early  90  by  Shigeru  Terabe  that  extends  the 
applicability of CE to neutral analytes, which cannot be 
separated using simple free solution CE. 
The same instrumentation that is used for CZE is used 
for  MEKC,  which  demonstrates  the  versatility  and 
adaptability of the  method. MEKC  differs from  CZE 
because it uses an ionic micellar solution instead of the 
simple buffer salt solution. MEKC can be used for the 
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applications of micellar   electrokinetic capillary chromatography, with   particular 
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separation of both ionic and neutral substances while 
CZE typically separates only ionic substances. Thereby 
MEKC  has  a  great  advantage  over  CZE  in  the 
separation of mixture containing both ionic and neutral 
analytes.
1,2,5 
The  separation  principle  of  MEKC  is  based  on  the 
differential partition  of the  analytes between  micelles 
and  water  while  CZE  is  based  on  the  differences 
between  the  own  electrophoretic  mobility  of  the 
analytes. 
 
Separation Principle 
MEKC is based on the addition to the buffer solution of 
a  micellar  “pseudostationary”  phase,  which  interacts 
with the analytes according to partitioning mechanisms, 
just  like  in  a  chromatographic  method.  The 
“pseudostationary” phase is composed of a surfactant 
added to the buffer solution in a concentration above its 
critical micellar concentration (CMC). In this system, 
EOF acts like a chromatographic “mobile phase”. From 
a “chromatographic point of view”, the EOF’s “plug-
like” flow profile is almost ideal as it minimizes band 
broadening,  which  can  occur  during  the  separation 
process.
5-7 
The  most  commonly  used  surfactant  sodium  dodecyl 
sulfate (SDS), an anionic surfactant. The anionic SDS 
micelles  are  electrostatically  attracted  towards  the 
anode. The EOF transports the bulk solution towards 
the negative electrode due to the negative charge on the 
internal surface of the silica capillaries. But the EOF is 
usually stronger than the electrophoretic migration  of 
the micelles and therefore the micelles will migrate also 
toward the negative electrode with a retarded velocity 
(Figure 1).
5-8,10 
 
 
Figure 1. Schematic of the separation principle in MEKC
5 
 
When  a  neutral  analyte  is  injected  into  the  micellar 
solution,  a  fraction  is  incorporated  into  the  micelle, 
while  the  remaining  fraction  of  the  analyte  migrates 
with  the  electroosmotic  velocity.  Consequently, 
micelles  decrease  selectively  the  migration  of  neutral 
solutes they interact with (by partitioning mechanism), 
which otherwise would migrate with the same velocity 
as the EOF. 
The separation depends on the individual partitioning 
equilibrium  of  the  different  analytes  between  the 
micellar and the aqueous phase. The greater percentage 
of analyte is distributed into the micelle, the slower it 
will  migrate.  Therefore,  analytes  that  have  greater 
affinity  for  the  micelles  exhibit  slower  migration 
velocities  compared  with  analytes  that  are  mostly 
distributed in the bulk solution.
2,5,8,10,11 
With SDS micelles, the general migration order will be 
exactly the opposite as in ECZ: anions, neutral analytes 
and  cations.  Anions  will  remain  mostly  in  the  bulk 
solution  due  to  electrostatic  repulsions  from  the 
micelle; neutral molecules will be separated exclusively 
due to their hydrophobicity; while cations will migrate 
last  due  to  the  strong  electrostatic  attraction.  This 
generalization  regarding  the  migration  order  can  be 
sometimes  useful,  but  strong  hydrophobic  interaction 
between analytes and micelles can overcome repulsions 
and  attractions.  Likewise,  the  own  electrophoretic 
mobilities of the analytes can also modify the migration 
order.
9,12 
Analytes which are highly retained by the micelle will 
have longer migration times, while analytes which have 
limited  interactions  with  the  micelle  will  have 
migration  times  close  to  the  EOF  (t0).  Very 
hydrophobic compounds may be totally included into 
the micelle and will migrate with the micelles velocity 
(tmc).  Methanol  is  not  retained  by  the  micelles  and 
migrates  with  t0 being  used  as  marker  for  the  EOF, 
while  a  dye  Sudan  III  is  totally  included  into  the 
micelle  and  can  be  used  as  a  micellar  marker.  The 
period between the migration time of the bulk solution 
and the migration time of the micelle is often referred 
to in the literature as migration time  window (Figure 
2).
5,8,13 
 
 
Figure 2. Migration time window in a MEKC separation
1 
 
A relatively recent development in MEKC has been to 
perform separations in the absence of EOF. This may 
be  achieved  using  coated  capillaries  or  at  low  pH 
values. This could be especially useful in the separation 
of  acidic  analytes,  which  would  ionized  at  high  pH 
values  and  would  not  interact  with  the  negatively 
charged SDS micelle.
15 
Cationic surfactants can be used in MEKC to reverse 
the charge on the capillary wall, by absorption on the 
capillary wall surface through a mechanism involving 
electrostatic attraction between the positively charged 
ammonium moieties and the negatively charged Si-O-
groups; when a reversal of the EOF takes place.
9 
Micelles and Surfactants 
Surfactants  are  molecules  with  detergent  properties, 
which  are  composed  of  a  hydrophilic  water-soluble 
head  group  and  a  hydrophobic  water-insoluble 
hydrocarbon chain group.  
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Although  a  large  number  of  surfactants  are 
commercially  available,  a  limited  number  are  widely 
used in MEKC separations. The surfactants suitable for 
MEKC must be soluble in the buffer solution to form 
micelles  and  the  micellar  solution  must  be 
homogeneous,  UV  transparent  and  also  have  a  low 
viscosity. 
There  are  four  major  classes  of  surfactants:  anionic, 
cationic, zwitterionic and nonionic (Table 1). Of these, 
ionic surfactants are generally used in MEKC. Every 
surfactant  has  a  characteristic  CMC  and  aggregation 
number (the number of surfactant molecules necessary 
to form a micelle). Another important parameter is the 
Kraft point, which represents the minimum temperature 
where the solubility of surfactants increases steeply due 
to the formation of micelles.
1,5,8,9 
 
Table 1. Surfactants classes and properties
1 
Surfactant  Type  CMC*  n 
Sodium dodecyl sulphate (SDS)  anionic  8.1 x 10
-3  62 
Sodium tetradecylsulphate (STS)  Anionic  2.1 x 10
-3  138 
Sodium dodecanesulphate  anionic  7.2 x 10
-3  54 
Sodium cholate  anionic  13-15 x 10
-3  2-4 
Cetyltrimethylammonium bromide (CTAB)  cationic  0.92 x 10
-3  61 
Dodecyltrimethylammonium bromide  cationic  15 x 10
-3  56 
Brij - 35  nonionic  0.1 x 10
-3  40 
Sulfobetaine  zwitterionic  3.3 x 10
-3  55 
 
Nonionic  surfactants  do  not  posses  electrophoretic 
mobility  and  cannot  be  used,  as  “pseudostationary 
phase” in conventional MEKC, however can be useful 
for the separation of charged analytes. This technique 
using  nonionic  micelles  can  be  classified  as  an 
extension of MEKC.
9,16 
Micelles  are  amphiphilic  aggregates  of  surfactants. 
Above  a  specific  surfactant  concentration,  the 
surfactant  molecules  begin  to  self-aggregate,  forming 
micelles,  spherical  aggregates  that  exhibit 
electrophoretic  migration  like  any  other  charged 
particle.  Micelles  are  long  chain  molecules  and  are 
characterized  as  possessing  a  long  hydrophobic  tails 
and a hydrophilic head group. Generally micelles are 
formed in aqueous solution with the hydrophobic tails 
oriented towards the center of the aggregated molecules 
and  the  hydrophilic  heads  pointing  outward  into  the 
aqueous solution.
6,9,10,12,14 
Micelle formation is a very dynamic process, as micelle 
disaggregate and reconstruct continuously, composing 
the  “pseudostationary  phase”  which  can  include 
hydrophobic analytes. 
Micellar  solutions  can  solubilize  hydrophobic 
compounds  which  otherwise  would  be  insoluble  in 
water.  Micelles  have  the  ability  to  interact  with  the 
analytes at molecular level based on hydrophobic and 
electrostatic  interactions.  Even  neutral  analytes  can 
bind to micelles due to the very strong solubilization 
power of the hydrophobic core.
8,9 
The micelles used in MEKC are charged on the surface, 
so  an  analyte  with  the  opposite  charge  will  strongly 
interact  with  the  micelle  through  electrostatic  forces 
while  an  analyte  with  the  same  charge  will  interact 
weakly due to the electrostatic repulsion. Therefore the 
use of a cationic or an anionic surfactant will result in 
an entirely different result. 
The  micellar  phase  can  be  modified  by  adding  two 
different surfactants to form a mixed micelle; addition 
of  an  ionic  and  a  nonionic  surfactant  can  provide 
different selectivity in separation. A mixed micelle has 
a lower surface charge and a larger size; consequently 
its electrophoretic mobility will be lower than the one 
of a simple ionic micelle.
8,9,12 
Some surfactants like bile salts are chiral and can be 
used for enantiomers separation.
16 
Buffer Additives 
Since  MEKC  is  often  applied  in  the  separation  of 
analytes  with  very  similar  hydrophobicities  and 
chemical characteristics, sometimes is useful to extend 
the  concept  of  using  a  “mobile  phase”  and  a 
“pseudostationary phase” to the use of buffer additives 
such as organic modifiers and cyclodextrines. 
Organic  solvents  (methanol,  acetonitrile)  are  used  in 
CZE in order to increase solubility of the analytes, but 
their  role  in  MEKC  is  more  complex  and  profound. 
Organic  solvents  reduce  EOF,  consequently  increase 
the migration times and migration time window of the 
analytes.  Also,  organic  additives  reduce  the 
hydrophobic interactions between the micelle and the 
analyte and can be useful in the separation of analytes 
which otherwise are almost completely incorporated in 
micelles. The addition of organic solvents will increase 
the migration  velocity  of  these  hydrophobic  analytes, 
by  reducing  the  partition  coefficient  between  the 
micelle  and  the  bulk  solution.  However  high 
concentration of organic solvents may break down the 
micellar  structure,  consequently  concentrations  above 
25-30% should be avoided.
1,5,6,8,11,13  
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Cyclodextrines  (CD)  are  cyclic  oligosaccharides  with 
truncated  cylindrical  molecular  shapes,  having  an 
external  hydrophilic  surface  and  an  internal 
hydrophobic  cavity,  in  which  they  can  include  other 
compounds by hydrophobic interactions. The inclusion 
mechanism  is  sterically  selective,  because  analytes 
must fit the size of the cavity, the diameter of which 
depends  on  the  number  of  glucose  units  in  the  CD 
structure.
17 
There is a wide range of both natural and derivatised 
CD commercially available. The native CD, α-, β-, and 
γ-CD possess different numbers of glucose  sub-units, 
six,  seven  and  eight  respectively.  These  surface 
hydroxyl  groups  can  be  chemically  replaced  with 
groups  such  as  hydroxypropy  and  dimethyl  groups. 
Ionic chargeable CD offers the possibility of separation 
of neutral drug enantiomers or enhanced separation of 
ionic drugs. Several CE specific derivatised CDs have 
been  produced  with  amino,  sulfate  or  carboxylic 
groups.
18 
Because of the chirality of the hydroxyls in the glucose 
molecules  that  form  the  rim  of  the  CD  cavity,  the 
inclusion complex formation will be chirally selective. 
If  the  enantiomers  of  a  compound  have  different 
binding constants, then chiral separation is possible by 
adding the proper CD in the buffer electrolyte.
16 
CDs are neutral from electrophoretic point of view, and 
are  not  incorporated  in  micelles,  because  of  the 
hydrophilic  nature  of  the  outside  surface  of  the 
molecules.  Therefore,  an  analyte  included  in  the  CD 
will migrate with the same velocity as the EOF. The 
addition  of  cyclodextrines  reduces  the  apparent 
distribution coefficient of the analytes between the two 
phases. 
Hydrophobic  analytes  can  become  incorporated  into 
either  the  CD  cavity  or  the  micelle.  Effectively  the 
addition of the CD establishes two “pseudo stationary” 
phases  in  the  electrolyte,  which  can  reduce  analysis 
times and offer the possibility of improved separation. 
CDs have advantages over organic solvents, as they are 
UV  transparent  and  non-volatile.  The  schematic 
principle  in  cyclodextrin  modified  micellar 
electrokinetic  chromatography  is  presented  (CD-
MEKC) (Figure 3).
1,5,16,17 
 
 
Figure 3. Schematic of the separation principle in CD – MEKC
5 
 
Theoretical Aspects 
In  MEKC  we  can  define  the  capacity  factor  (k) 
similarly as in chromatography:
5 
k = nmc / naq 
wherenmc and naqare the amount of analyte incorporated 
into the micelle and in the aqueous respectively. It can 
be  calculated  from  the  migration  time  of  the  analyte 
(tR), of the EOF (t0) and of the micelle (tmc):
5 
k = tR-t0 / t0(1- tR/tmc) 
When k = 0, the migration time of the analyte is equal 
to  t0,  which  means  that  the  analyte  does  not  interact 
with the micelle; and when k is infinity, the migration 
time of the analyte is equal to tmc, which means that the 
analyte is totally incorporated into the micelle. 
The  capacity  factor  is  a  fundamental  term  in 
chromatography  while  the  electrophoretic  mobility  is 
characteristic to the electrophoretic process. In ECZ the 
migration  velocity  (v)  of  the  analyte  is  expressed 
as:
5,7,19 
v = (μeo + μa) E 
whereμeo and μa are the electrophoretic mobilities of the 
EOF and analyte respectively and E is the electric field 
strength.  We  can  apply  this  equation  to  MEKC  by 
defining  the  effective  electrophoretic  mobility  of  a 
neutral analyte (μna) as:
5,7,19 
μna = μmc k/1+k 
whereμmc is the electrophoretic mobility of the micelle 
and  k/1+k  represents  the  fraction  of  analyte 
incorporated into the micelle. Thus, the velocity of a 
neutral analyte in MEKC is given as:
5,7 
v = (μeo + μna) E 
The  capacity  factor  provides  quantitative  information 
about the analyte distribution between the two phases, 
while  the  electrophoretic  mobility  only  gives 
qualitative information about it. 
The resolution equation in MEKC can be given by the 
following equation:
1,5,19,20 
 
where  N  is  the  theoretical  plate  number,  α  the 
separation factor between the two analytes and k1 and 
k2 their capacity factor. 
The separation factor (α) is determined by the micellar 
solubilization process and is influenced by the chemical 
nature of both the micellar and aqueous phase. Various 
surfactant  systems  can  be  used  as  well  as  mixed 
micelles,  possessing  different  solubilization 
characteristics, in order to control migration behavior 
of the analytes and optimize selectivity. 
 
Method Development Guidelines 
Micellar  solutions  exhibit  a  relatively  high 
conductivity, so a capillary with small diameter could 
be the right choice to prevent excessive Joule heating. 
A longer capillary can be useful in the case of large  
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amount sample solutions to obtain a better separation at 
the expense of time.
1 
The  micellar  solution  is  prepared  by  dissolving  the 
surfactant  in  the  buffer  solution  in  a  concentration 
above its CMC. Popular buffer solutions often used to 
prepare the micellar solution are phosphate, borate, or 
tris  (hydroxymethyl)  aminomethane  (Tris). 
Concentrations between 25 and 100 mM are normally 
employed  for  both  the  surfactant  and  buffer.  High 
concentrations will result in relatively high viscosities 
and high currents and should be avoided. It is essential 
that  the  pH  of  the  buffer  remains  constant,  being  a 
critical  parameter  in  the  separation  of  ionizable 
analytes.
1,13 
It  should  be  noted  that  the  counter  ion  of  the  ionic 
surfactant is exchanged by the counter ion of the buffer 
electrolyte  and,  consequently,  the  character  of  the 
micelle may be changed.
1 
The sample solution can be prepared in any solvent; but 
water will be the first choice solvent if the analyte is 
soluble  in  it.  When  the  sample  contains  high 
concentrations of an organic solvent, the peaks may be 
split due to incomplete mixing of the sample solution 
with the running solution.
1 
The applied voltage must be kept to a level that doesn’t 
generate excessive current, the limit being determined 
by  the  capacity  of  the  electrophoretic  system  to 
dissipate  Joule  heating.  A  compromise  is,  therefore, 
necessary  between  high  Joule  heating  and  fast 
separation time.
1 
It is also necessary to control the capillary temperature 
because  MEKC  methods  are  even  more  sensitive  to 
temperature  variation  than  CZE  methods.  The 
distribution  coefficients  are  highly  dependent  on 
temperature;  an  increase  in  temperature  will  cause  a 
decrease in the distribution coefficient of the analytes 
between  the  two  phases.  It  is  well  known  that  an 
increase in temperature reduces viscosity of the buffer, 
which  increases  both  electrophoretic  and  EOF 
velocities, reducing the migration time.
1,5,13 
When preliminary runs show unsatisfactory separation, 
several analytical parameters may need to be adjusted 
in order to optimize separation. It is useful to estimate 
the  retention  factors  by  measuring  t0  and  tmc.  If 
problems  occur  in  measuring  tmcdue  to  the  difﬁculty 
observing the  micelle  marker  peak, it  is  advisable  to 
simply assume that tmcis four time longer than t0. The 
optimum  value  of  the  capacity  factor  k  can  be 
estimated as being equal to (tmc/t0)
1/2. 
1,5,8,13 
If  optimum  k  values  do  not  provide  acceptable 
resolution, further tuning may be required; the use of 
additives  such  as  organic  solvents  or  CDs  may  be 
needed, or the use of alternate surfactants may prove 
effective.  The  selection  of  additives  is  extensive,  but 
the first step is recommended to be the addition of an 
organic  solvent  in  low  concentration.  If  the  analytes 
have  closely  related  structures,  addition  of  a  CD 
derivative  may  prove  effective.  There  are  many 
different CD derivatives available, but initially ß-CD or 
γ-CD can be tested. Further steps can be performed by 
selecting  other  CD  derivatives  if  necessary.  Another 
choice  is  the  modiﬁcation  of  the  micelle  by  using 
mixed  micelles,  in  particular,  addition  of  a  nonionic, 
adding cosurfactants, or by adding an organic counter 
ion.
1,5,8,13 
One of the issues that still remains unsolved in MEKC 
is  the  improvement  in  reproducibility  in  quantitative 
analysis, including migration time and peak height or 
peak  area,  a  problem  characteristic  for  every  CE 
technique.
2,5 
 
MEKC  Applications  in  the  Analysis  of 
Pharmaceutical Substances 
In principle MEKC is used for the analysis of neutral 
compounds, or when analyzing mixtures of neutral and 
charged  solutes.  But  MEKC  conditions  are  also 
employed  when  selectivity  requirements  for  a 
separation  exceed  the  simple  mobility  differences 
obtainable in CZE. 
MEKC can be especially useful for the determination 
of  drugs  in  samples  having  a  high  protein  content 
(clinical  samples,  biofluids)  reducing  the 
disadvantageous  matrix  effects  caused  by  organic 
materials,  while  CZE  through  its  simplicity  and 
operation  stability  could  be  advantageous  for 
pharmaceutical determinations. MEKC can be usually 
applied  in  simultaneous  separation  from  complex 
mixtures  of  pharmaceutical  substances  with  very 
similar structural and physico-chemical characteristics. 
Many reports have been published detailing the use of 
MEKC  for  pharmaceutical  applications;  Table  2 
presents  briefly  selected  pharmaceutical  applications 
and the description of the electrophoretic conditions. 
Another application of MEKC is the chiral separation 
of  optically  active  pharmaceutical  substances. 
Enantiomer separation by MEKC involves the addition 
of  a  chiral  agent  such  as  chiral  surfactants,  crown 
ethers,  or  CDs  to  the  background  electrolyte  with 
chiral/achiral  micelles.  Chiral  MEKC  with  chiral 
surfactants is an important separation mode for chiral 
compounds,  with  chiral  surfactants  including  also 
naturally  occurring  compounds  such  as  bile  salts, 
amino acids or glucose.
37 
Chiral separation in MEKC is affected by the affinity 
of  the  enantiomers  toward  the  micelles,  and  the 
concentration of the micellar phase, which depends on 
the aggregation properties of the chiral surfactants.
1 
MEKC  can  be  used  for  the  separation  of  structural 
related impurities from the main active drug, and has 
been proven an alternative to HPLC for quantitation of 
compounds  and  the  determination  of  drug-related 
impurities.
1 
The  structurally  related  impurities  of  a  drug  will 
possess  similar  structural  and  physico-chemical 
characteristics  to  the  main  component,  which  makes 
their separation and determination a challenging task. 
The high separation efficiencies possible for CE often 
allows  a  small  degree  of  selectivity  to  provide  an  
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acceptable resolution. The separation and determination 
of  drug-related  impurities  using  CE  has  been 
extensively studied, and the method performance and 
validation data obtained clearly shows that CE methods 
are successful applications in this area. 
 
Table 2. Applications of MEKC in the analysis of different pharmaceutical substances 
Pharmaceutical 
class 
Substances  Electrophoretic conditions  Reference 
Penicillins 
Amoxicillin, Ampicillin, Benzylpenicillin, 
Phenoxymethypenicillin, Oxacillin, 
Cloxacilin 
40 mM sodium tetraborate + 100 mM SDS, pH – 9.3 
voltage: + 10kV, temperature: 20 
0C, UV detection 210 
nm 
21 
Penicillins 
Amoxicillin, Ampicillin, Benzylpenicillin, 
Phenoxymethypenicillin, Oxacillin, 
Cloxacilin, Dicloxacillin, Nafcillin, 
Piperacillin 
26 mM sodium tetraborate + 100 mM SDS, pH – 8.5 
voltage: + 20kV, temperature: 30 
0C, UV detection 220 
nm 
22 
Cephalosporins 
Cefazoline, Cefuroxime, Ceftriaxone, 
Cefoperazone, Ceftazidime 
20 mM sodium tetraborate + 15 mM disodium 
hydrogenophosphate + 50 mM SDS 
pH – 6.5, voltage: + 18kV, temperature: 20
0C, UV 
detection 214 nm 
23 
Macrolides 
Erythromycin, Tylosin and related 
substances 
80 mM sodium phosphate + 20 mM sodium cholate + 7 
mMcetyltrimethylammonium bromide, pH – 7.5, 
voltage: + 15kV, temperature: 25
0C, UV detection 280 
nm 
24 
Aminoglycosides 
Gentamicin, Sisomicin, Netilmicin, 
Kanamycin, Amikacin, Tobramycin 
100 mM sodium tetraborate + 20 mM sodium 
deoxycholate + 15 mM beta-cyclodextrin, pH – 10 
voltage: + 20kV, temperature: 25
0C 
25 
Tetracyclines 
Tetracycline, Oxytetracicline, 
Democlocycline, Chlortetracycline, 
Doxycicline, Minocycline 
15 mM ammonium acetate + 20 mM SDS, pH – 6.5, 
voltage: + 15kV, temperature: 25
0C 
26 
Sulfonamides 
Sulfanilamide, Sulfathiazole, 
Sulfamethoxazole, Sulfaguanidine, 
Sulfadiazine 
13.32 mM disodium hydrogen phosphate, 6.67 mM 
potassium dihydrogen phosphate + 40 mM SDS, pH – 
7.5, voltage: + 21kV, temperature: 25
0C 
fluorescence detection 
27 
Sulfonamides 
Sulfamethazine, Sulfamerazine, 
Sulfathiazole, Sulfachloropyridazine, 
Sulfamethoxazole, Sulfacarbamide, 
Sulfaguanidine 
15 mM sodium tetraborate  + 25 mM SDS + 20% 
methanol, pH – 9.3, voltage: + 20kV, temperature: 
22
0C, UV detection 200 nm 
28 
Fluoroquinolones 
Norfloxacin, Ciprofloxacin, Ofloxacin, 
Enrofloxacin, Danofloxacin 
25 mM sodium carbonate + 100 mM SDS, pH – 9.2, 
voltage: + 20kV, temperature: 30
0C, UV detection 280 
nm 
29 
Antifungal azoles 
Fluconazole, Voriconazole, Itraconazole, 
Posaconazole 
25 mM phosphoric acid + 100 mM SDS + 13 % 
acetonitrile + 13 % tetrahydrofuran, pH – 2.2 
30 
Barbiturates 
Phenobarbital, Amobarbital, Pentobarbital, 
Secobarbital, Butabarbital 
10 mM sodium tetraborate + 10 mM disodium 
hydrogenophosphate + 100 mM SDS + 15% 
acetonitrile. pH - 8.5, voltage: + 20 kV, UV detection 
214 nm 
31 
Benzodiazepines 
Flunitrazepam, Diazepam, Midazolam, 
Clonazepam, Bromazepam, Temazepam, 
Oxazepam, Lorazepam 
25 mM phosphate/borate + 75 mM SDS, pH – 9.3  32 
Benzodiazepines 
Alprazolam, Bromazepam, 
Chlordiazepoxide, Diazepam, 
Flunitrazepam, Medazepam, Oxazepam, 
Nitrazepam 
25 mM sodium tetraborate + 50 mM SDS + 12% 
methanol, pH – 9.3, voltage: + 25kV, temperature: 20 
0C, UV detection 214 nm 
33 
Phenotiazines 
Promethazino, Ethopropazine, 
Trimeprazine, Methoprimeprazine, 
Thioridazine 
80 mM citric acid + 10 
mMtetradecyltrimethylammonium bromide + 7 mM β-
CD (9 mM HP β-CD), pH – 3.5, voltage: + 20kV, 
temperature: 25 
0C, UV detection 254 nm 
enantiomer separation 
34 
Tricyclic 
antidepressants 
Imipramine, Amitriptyline, Desipramine, 
Nortriptyline, Doxepin, Trimipramine 
37.5 mM phosphate + 25 
mMdodecyltrimethylammonium bromide + 2 M urea, 
pH – 8, voltage: + 25kV 
35 
Xanthines 
Caffeine, Theobromine, Theophylline, 
Pentoxifylline 
20 mM sodium tetraborate + 100 mM SDS, pH – 9.3, 
voltage: + 30kV, temperature: 25 
0C, UV detection 274 
nm 
36 
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During  the  early  phase  and  later  phase  of  drug 
development, knowledge of physiochemical properties 
of pharmaceutical compounds is important in order to 
predict  their  bioavailability  and  blood-brain. 
Physicochemical  properties  such  as  acid  dissociation 
constant  (pKa),  octanol–water  partition-coefficient 
(logP), solubility, permeability, and protein binding are 
closely  related  to  drug  absorption,  distribution, 
metabolism, and excretion. The pKa determination of 
acids  and  bases  by  CE  is  based  on  measuring  the 
electrophoretic mobility of charged species associated 
with the acid–baseequilibria as a function of pH. CE 
techniques  using  “pseudostationary”  phases  in  the 
background  electrolyte,  like  MEKC,  allow  the 
measurement of log Pvalues because of the partitioning 
of solutes between the micellar and the aqueous phase. 
CE  methods  and  especially  MEKC  has  been  applied 
successfully  for  physicochemical  analysis  of  many 
pharmaceutical  compounds  and  has  many  advantages 
over  the  traditional  methods  of  log  P  and  pKa 
determination.
38,39 
 
Concluding remarks 
The use of CE methods in pharmaceutical analysis has 
become increasingly popular in recent years. The wide 
range of applications for which the use of this method 
has proved to be successful includes identification of 
pharmaceutical  substances,  assay  of  drugs, 
determination  of  drug-related  impurities, 
physicochemical  measurements  of  drug  molecules  or 
chiral separations.
11,19,20 
For pharmaceutical analysis, the range of applications 
for  which  CE  can  be  used  is  extensive,  possibly 
eclipsing the applications of the more frequently used 
HPLC.  CE  also  offers  a  number  of  advantages  over 
HPLC  and  other  analytical  techniques:  the  rapid 
development of the analysis method, its analysis speed, 
reduced consumable and solvent expenses, low sample 
amount,  simplicity  of  operations,  and  a  greater 
possibility of implementation of a single set of method 
conditions  for  the  analysis  of  several  different 
samples.
1 
MEKC is a branch of CE, which has become during the 
years one of the most popular techniques in CE due to 
its  high  resolving  power  and  capability  of  separating 
both  ionic  and  neutral  analytes.  MEKC  is  the  most 
flexible  of  all  CE  techniques,  offering  the  greatest 
selectivity to the widest range of compounds and can 
be  considered  the  separation  method  of  choice  when 
performing CE analysis for pharmaceutical substances. 
MEKC  combines  the  separation  mechanism  of 
chromatography  with  the  electrophoretic  and 
electroosmotic movement of analytes and solutions for 
the separation of constituents in a sample. 
In the last 10-15 years MEKC gained popularity among 
separation  scientist  as  pointed  out  by  the  relatively 
large numbers of article published, therefore this papers 
main  objective  is  to  present  the  guiding  principles 
regarding the full availability of the technique. 
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